ENDRA Life Sciences, Inc. (NDRA)
5.89
-0.02
(-0.25%)
USD |
NASDAQ |
Sep 09, 16:00
5.89
0.00 (0.00%)
After-Hours: 19:00
ENDRA Life Sciences Shareholders Equity (Quarterly) : 6.310M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.310M |
| March 31, 2026 | 1.787M |
| December 31, 2025 | 2.260M |
| September 30, 2025 | 0.1714M |
| June 30, 2025 | 1.473M |
| March 31, 2025 | 1.753M |
| December 31, 2024 | 2.560M |
| September 30, 2024 | 6.605M |
| June 30, 2024 | 8.994M |
| March 31, 2024 | 3.698M |
| December 31, 2023 | 5.659M |
| September 30, 2023 | 5.196M |
| June 30, 2023 | 6.931M |
| March 31, 2023 | 4.499M |
| December 31, 2022 | 7.204M |
| September 30, 2022 | 10.20M |
| June 30, 2022 | 13.33M |
| March 31, 2022 | 9.069M |
| December 31, 2021 | 10.78M |
| September 30, 2021 | 13.16M |
| June 30, 2021 | 14.99M |
| March 31, 2021 | 17.85M |
| Date | Value |
|---|---|
| December 31, 2020 | 7.169M |
| September 30, 2020 | 3.335M |
| June 30, 2020 | 0.9769M |
| March 31, 2020 | 2.522M |
| December 31, 2019 | 4.761M |
| September 30, 2019 | 1.403M |
| June 30, 2019 | 1.824M |
| March 31, 2019 | 3.802M |
| December 31, 2018 | 6.248M |
| September 30, 2018 | -0.4576M |
| June 30, 2018 | 1.941M |
| March 31, 2018 | 2.830M |
| December 31, 2017 | 5.276M |
| September 30, 2017 | 7.168M |
| June 30, 2017 | 7.782M |
| March 31, 2017 | -1.380M |
| December 31, 2016 | -0.8938M |
| September 30, 2016 | -0.2412M |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.2503M |
| September 30, 2015 | 0.2503M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Accuray, Inc. | 41.70M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 429.18M |
| ResMed, Inc. | 6.585B |
| Rockwell Medical, Inc. | 35.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.942M |
| Total Liabilities (Quarterly) | 1.632M |
| Debt to Equity Ratio | 0.068 |
| Current Ratio | 7.103 |
| Net Debt Paydown Yield | 0.40% |